Gabapentin Capsule
Product Images NDC 53746-101

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 53746-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Gabapentin Capsules Usp 1)

This text appears to be a set of medical instructions or calculations for determining a patient's ClCr (Creatinine Clearance) level based on their age, weight, and serum creatinine levels. However, without more context or information about the specific medical situation, it is difficult to provide a more specific description or interpretation.*

FDA Label Image

Structural Formula (Gabapentin Capsules Usp 2)

FDA Label Image

Figure 1 (Gabapentin Capsules Usp 3)

The text describes a chart of pain scores on a scale of 1 to 10 over an 8 week period, with a dose titration period followed by a fixed dose period. The chart displays the pain scores for both a placebo and a medication called Gabapentin, with a daily dose of 3600 mg. The chart starts at baseline and displays pain scores for each week.*

FDA Label Image

Figure 2 (Gabapentin Capsules Usp 4)

This is a clinical chart that shows the mean pain score over a period of seven weeks. The chart displays the pain scores for a placebo group, a group taking gabapentin at a dose of 1800 mg/day, and a group taking gabapentin at a dose of 2400 mg/day. There was a 3-week dose titration period and a subsequent 4-week fixed dose period. The baseline pain score is not specified.*

FDA Label Image

Figure 3 (Gabapentin Capsules Usp 5)

This appears to be a graph or chart showing the results of two studies with different treatments (PBO, GBP 3600, GBP 1800, GBP 2400). The graph shows percentages ranging from 0% to 100%, with asterisks indicating statistical significance for certain data points. Without additional context, it is not possible to provide a more specific description of the content of the graph.*

FDA Label Image

Figure 4 (Gabapentin Capsules Usp 6)

FDA Label Image

100 Ct. (Gabapentin Capsules Usp 7)

This is a description of gabapentin capsules, USP with NDC number 53746-101-30. Each capsule contains 100 mg of gabapentin. It is prescribed medication and should be dispensed with a medication guide, and is only available by prescription. It is recommended to store at 20-25°C and dispense in tight, child-resistant containers. The medication is distributed by Amneal Pharmaceuticals LLC from Bridgewater.*

FDA Label Image

100 Ct. (Gabapentin Capsules Usp 8)

This is a product description for Gabapentin capsules. Each capsule contains 300mg of gabapentin. The recommended storage temperature is between 20°C to 25°C with an allowable range of 15°C to 30°C. Gabapentin capsules should be dispensed by pharmacists in tight (USP) and child-resistant containers along with medication guide provided separately. The product is distributed by Amneal Pharmaceuticals LLC.*

FDA Label Image

100 Ct. (Gabapentin Capsules Usp 9)

These are capsules with the National Drug Code 53746-103-30 containing 400 mg of gabapentin. They should be stored at temperatures between 20-25°C, with excursions permitted between 15-30°C. The recommended dosage should be taken as per the package insert instructions. The capsules are dispensed in child-resistant containers. The product is distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ. A guide is provided separately.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.